Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes
about
Current status of transarterial radioembolizationEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsRadioembolization of hepatic tumorsRole of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionAggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine TumorsVariable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesRadioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results.Zollinger-Ellison syndrome: recent advances and controversies.Surgical management of noncolorectal cancer liver metastases.Advances in understanding of colorectal liver metastasis and implications for the clinic.Therapeutic strategies for neuroendocrine liver metastases.Liver metastases from neuroendocrine tumors.(90)Y-glass microspheres for hepatic neoplasia.Transarterial approaches to primary and secondary hepatic malignancies.Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.Metastatic Malignant Paraganglioma: A Case Report and Review of Literature.90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.Superiority of proximal embolization of the gastroduodenal artery with the Amplatzer vascular plug 4 before yttrium-90 radioembolization: a retrospective comparison with coils in 134 patients.Radioembolization Versus Bland Embolization for Hepatic Metastases from Small Intestinal Neuroendocrine Tumors: Short-Term Results of a Randomized Clinical Trial.Liver transarterial embolizations in metastatic neuroendocrine tumors.Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study.Towards new response criteria in neuroendocrine tumors: which changes in MRI parameters are associated with longer progression-free survival after radioembolization of liver metastases?
P2860
Q26744307-0EDD35A0-079B-47F3-B481-004BA6A60D2EQ26799046-39CD0503-9828-4FA6-A752-3A66C9945CE4Q33820777-FB88F22E-7172-47BF-A6ED-F78E89770933Q34702065-6F53BB46-3EC9-4599-8E55-0C5F8AEA45B2Q35018379-C7EB9DDD-1193-42BF-B08C-4E819D05B4BDQ36153131-171AE57F-3B15-4054-8BF8-0D79F5BC6EB8Q36284669-95CA95C3-6874-4F0B-AA5E-B7713F5D7148Q36980633-E59F39C4-C768-44D6-A1F7-E24AF1A4F136Q37125550-D3976769-788F-4C81-A84C-81EFBA784339Q37525291-AC820F9B-E91A-4FD2-9427-78EE7AAF6A41Q37671474-2A5D33DD-6E75-470F-8F0C-7CFC6D8F529BQ38150165-80019B94-9301-4FBF-9C7E-BE6920D64817Q38224364-032C0E21-B34F-4B49-82A7-AA79EFBECE0BQ38230654-38E6CA10-C219-4EBB-9A33-9FE5349FD68AQ38255979-629EE5BA-CE5A-47E3-9F1A-B3957B3B812DQ38283682-7C309B94-A892-423F-A1E9-7FD42E86C3B0Q38465831-01BB81C1-180F-4F58-80EA-47D075685B8FQ38488732-EF0DFB1B-08D0-486A-A6F5-96CEF8D5D7ECQ38693622-61319413-0D81-4FC1-BD95-D3264662BE37Q39349632-D17E54D8-71CC-4765-8DC8-5CD1F7702158Q39456177-5D3F99BB-F2FE-4BF7-A2AD-6EC1DB7882B7Q40071417-E8EE9BC3-8EF4-4869-8934-362ED847EBC1Q40542715-00C1725D-1EA0-4B7F-892D-65E26FA07C86Q43775926-A4C82328-ADE4-4A63-8CE1-5AC59B581C4AQ45207818-E936C1C9-5D74-4E01-AF2E-9D8E8A7205E6Q46145425-F5978F44-9C9E-493B-BCE2-CDC933135CC4Q47425435-0D94DC5C-63F2-4C66-9E80-7BB05470ECF0Q47869784-542B4886-2F43-4213-AF49-4ACF17427696Q48377564-4244FD43-AA06-4B26-9D3E-C77C7F0DFD2BQ53635873-9B1EAA55-D0C5-40B5-A507-06E7FCCFD3AB
P2860
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Radioembolization for neuroend ...... maging, and long-term outcomes
@ast
Radioembolization for neuroend ...... maging, and long-term outcomes
@en
type
label
Radioembolization for neuroend ...... maging, and long-term outcomes
@ast
Radioembolization for neuroend ...... maging, and long-term outcomes
@en
prefLabel
Radioembolization for neuroend ...... maging, and long-term outcomes
@ast
Radioembolization for neuroend ...... maging, and long-term outcomes
@en
P2093
P2860
P50
P1476
Radioembolization for neuroend ...... maging, and long-term outcomes
@en
P2093
Al B Benson
Bassel Atassi
Frank H Miller
Kent T Sato
Khairuddin Memon
Mary F Mulcahy
Paul Nikolaidis
Ramona Gupta
Reed A Omary
Robert J Lewandowski
P2860
P304
P356
10.1016/J.IJROBP.2011.07.041
P407
P577
2011-12-02T00:00:00Z